Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.
The inflammasome is a multi-protein complex which when activated regulates caspase-1 activation and IL-1β secretion. Inflammasome activation is mediated by NLR proteins that respond to stimuli. Among NLRs, NLRP3 senses the widest array of stimuli. NLRP3 inflammasome plays an important role in the de...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3935965?pdf=render |
id |
doaj-15974f7625d9453eb10b8b438071c3d5 |
---|---|
record_format |
Article |
spelling |
doaj-15974f7625d9453eb10b8b438071c3d52020-11-24T21:51:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8996110.1371/journal.pone.0089961Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome.Shao-hua FanYan-yan WangJun LuYuan-lin ZhengDong-mei WuMeng-qiu LiBin HuZi-feng ZhangWei ChengQun ShanThe inflammasome is a multi-protein complex which when activated regulates caspase-1 activation and IL-1β secretion. Inflammasome activation is mediated by NLR proteins that respond to stimuli. Among NLRs, NLRP3 senses the widest array of stimuli. NLRP3 inflammasome plays an important role in the development of many cancer types. However, Whether NLRP3 inflammasome plays an important role in the process of hepatocellular carcinoma (HCC) is still unknown. Here, the anticancer effect of luteoloside, a naturally occurring flavonoid isolated from the medicinal plant Gentiana macrophylla, against HCC cells and the underlying mechanisms were investigated. Luteoloside significantly inhibited the proliferation of HCC cells in vitro and in vivo. Live-cell imaging and transwell assays showed that the migration and invasive capacities of HCC cells, which were treated with luteoloside, were significantly inhibited compared with the control cells. The inhibitory effect of luteoloside on metastasis was also observed in vivo in male BALB/c-nu/nu mouse lung metastasis model. Further studies showed that luteoloside could significantly reduce the intracellular reactive oxygen species (ROS) accumulation. The decreased levels of ROS induced by luteoloside was accompanied by decrease in expression of NLRP3 inflammasome resulting in decrease in proteolytic cleavage of caspase-1. Inactivation of caspase-1 by luteoloside resulted in inhibition of IL-1β. Thus, luteoloside exerts its inhibitory effect on proliferation, invasion and metastasis of HCC cells through inhibition of NLRP3 inflammasome. Our results indicate that luteoloside can be a potential therapeutic agent not only as an adjuvant therapy for HCC, but also, in the control and prevention of metastatic HCC.http://europepmc.org/articles/PMC3935965?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shao-hua Fan Yan-yan Wang Jun Lu Yuan-lin Zheng Dong-mei Wu Meng-qiu Li Bin Hu Zi-feng Zhang Wei Cheng Qun Shan |
spellingShingle |
Shao-hua Fan Yan-yan Wang Jun Lu Yuan-lin Zheng Dong-mei Wu Meng-qiu Li Bin Hu Zi-feng Zhang Wei Cheng Qun Shan Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome. PLoS ONE |
author_facet |
Shao-hua Fan Yan-yan Wang Jun Lu Yuan-lin Zheng Dong-mei Wu Meng-qiu Li Bin Hu Zi-feng Zhang Wei Cheng Qun Shan |
author_sort |
Shao-hua Fan |
title |
Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome. |
title_short |
Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome. |
title_full |
Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome. |
title_fullStr |
Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome. |
title_full_unstemmed |
Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome. |
title_sort |
luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of nlrp3 inflammasome. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
The inflammasome is a multi-protein complex which when activated regulates caspase-1 activation and IL-1β secretion. Inflammasome activation is mediated by NLR proteins that respond to stimuli. Among NLRs, NLRP3 senses the widest array of stimuli. NLRP3 inflammasome plays an important role in the development of many cancer types. However, Whether NLRP3 inflammasome plays an important role in the process of hepatocellular carcinoma (HCC) is still unknown. Here, the anticancer effect of luteoloside, a naturally occurring flavonoid isolated from the medicinal plant Gentiana macrophylla, against HCC cells and the underlying mechanisms were investigated. Luteoloside significantly inhibited the proliferation of HCC cells in vitro and in vivo. Live-cell imaging and transwell assays showed that the migration and invasive capacities of HCC cells, which were treated with luteoloside, were significantly inhibited compared with the control cells. The inhibitory effect of luteoloside on metastasis was also observed in vivo in male BALB/c-nu/nu mouse lung metastasis model. Further studies showed that luteoloside could significantly reduce the intracellular reactive oxygen species (ROS) accumulation. The decreased levels of ROS induced by luteoloside was accompanied by decrease in expression of NLRP3 inflammasome resulting in decrease in proteolytic cleavage of caspase-1. Inactivation of caspase-1 by luteoloside resulted in inhibition of IL-1β. Thus, luteoloside exerts its inhibitory effect on proliferation, invasion and metastasis of HCC cells through inhibition of NLRP3 inflammasome. Our results indicate that luteoloside can be a potential therapeutic agent not only as an adjuvant therapy for HCC, but also, in the control and prevention of metastatic HCC. |
url |
http://europepmc.org/articles/PMC3935965?pdf=render |
work_keys_str_mv |
AT shaohuafan luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome AT yanyanwang luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome AT junlu luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome AT yuanlinzheng luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome AT dongmeiwu luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome AT mengqiuli luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome AT binhu luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome AT zifengzhang luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome AT weicheng luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome AT qunshan luteolosidesuppressesproliferationandmetastasisofhepatocellularcarcinomacellsbyinhibitionofnlrp3inflammasome |
_version_ |
1725880903098433536 |